Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) study
Cancer · 2026
DOI: 10.1002/cncr.70210 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, 2026. Verfasst von Irfan Yasin und 27 weiteren Autor:innen. Beteiligte Einrichtung: Pathology (Hematology/Oncology & Hematopathology & Genomic Pathology & Cytogenetics), Medicine (Hematology/Oncology), The University of Chicago Medic…. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Chromosomes, Human, Pair 5, Chromosome Aberrations, Myelodysplastic Syndromes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background Isolated chromosome 5/5q losses (–5/5q) without TP53 mutations are associated with favorable outcomes in myeloid neoplasms (MN) with
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pathology (Hematology/Oncology & Hematopathology & Genomic Pathology & Cytogenetics), Medicine (Hematology/Oncology), The University of Chicago Medicine, Chicago, Illinois, USA.
- Munich Leukemia Laboratory, Munich, Germany.
- Pathology (Hematopathology), Medicine (Hematology Oncology), H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA.
- Pathology (Molecular Pathology), Endeavor Health Northshore Hospital, Evanston, Illinois, USA.
- Pathology, Microbiology, and Immunology (Hematopathology), Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Pathology (Hematopathology), University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
ORCID-Profile: Irfan Yasin, Pranav P Patwardhan, Ayalew Tefferi, Talha Badar, Girish Venkataraman
Zitieren
APA
Yasin, I., Stengel, A., Shao, H., Kaur, A., Mason, E. F., Patwardhan, P. P., Bailey, N. G., Ghosh, S., Inamdar, K. V., Patel, A. A., Pandiri, M., Zhang, J., Sojitra, P., Tariq, H., Pan, Z., Wiredja, D., Wang, P., Tjota, M. Y., Segal, J. P., …, & Venkataraman, G. (2026). Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) study. Cancer. https://doi.org/10.1002/cncr.70210
Vancouver
Yasin I, Stengel A, Shao H, Kaur A, Mason EF, Patwardhan PP, et al. Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) study. Cancer. 2026. doi:10.1002/cncr.70210
BibTeX
@article{Yasin2026,
author = {Yasin, Irfan and Stengel, Anna and Shao, Haipeng and Kaur, Amandeep and Mason, Emily F and Patwardhan, Pranav P and Bailey, Nathanael G and Ghosh, Sharmila and Inamdar, Kedar V and Patel, Anand A and Pandiri, Madhavi and Zhang, Jingjing and Sojitra, Payal and Tariq, Hamza and Pan, Zenggang and Wiredja, Danica and Wang, Peng and Tjota, Melissa Y and Segal, Jeremy P and Chang, Hong and Sallman, David A and Arber, Daniel A and Tefferi, Ayalew and Badar, Talha and Perry, Anamarija M and Haferlach, Claudia and Lager, Angela M and Venkataraman, Girish},
title = {Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) study},
journal = {Cancer},
year = {2026},
doi = {10.1002/cncr.70210}
}
EUVIMED